160 related articles for article (PubMed ID: 18528463)
1. Enhancing or eliminating signals for cell survival to treat disease.
Tweardy DJ; Jing N
Trans Am Clin Climatol Assoc; 2006; 117():33-51; discussion 51-2. PubMed ID: 18528463
[TBL] [Abstract][Full Text] [Related]
2. G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis.
Jing N; Li Y; Xiong W; Sha W; Jing L; Tweardy DJ
Cancer Res; 2004 Sep; 64(18):6603-9. PubMed ID: 15374974
[TBL] [Abstract][Full Text] [Related]
3. Prevention of hypovolemic circulatory collapse by IL-6 activated Stat3.
Alten JA; Moran A; Tsimelzon AI; Mastrangelo MA; Hilsenbeck SG; Poli V; Tweardy DJ
PLoS One; 2008 Feb; 3(2):e1605. PubMed ID: 18270592
[TBL] [Abstract][Full Text] [Related]
4. Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer.
Jing N; Zhu Q; Yuan P; Li Y; Mao L; Tweardy DJ
Mol Cancer Ther; 2006 Feb; 5(2):279-86. PubMed ID: 16505101
[TBL] [Abstract][Full Text] [Related]
5. T40214/PEI complex: a potent therapeutics for prostate cancer that targets STAT3 signaling.
Weerasinghe P; Li Y; Guan Y; Zhang R; Tweardy DJ; Jing N
Prostate; 2008 Sep; 68(13):1430-42. PubMed ID: 18615483
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.
Weerasinghe P; Garcia GE; Zhu Q; Yuan P; Feng L; Mao L; Jing N
Int J Oncol; 2007 Jul; 31(1):129-36. PubMed ID: 17549413
[TBL] [Abstract][Full Text] [Related]
7. Prevention of trauma/hemorrhagic shock-induced lung apoptosis by IL-6-mediated activation of Stat3.
Moran A; Tsimelzon AI; Mastrangelo MA; Wu Y; Yu B; Hilsenbeck SG; Poli V; Tweardy DJ
Clin Transl Sci; 2009 Feb; 2(1):41-9. PubMed ID: 20443866
[TBL] [Abstract][Full Text] [Related]
8. Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer.
Bharadwaj U; Eckols TK; Kolosov M; Kasembeli MM; Adam A; Torres D; Zhang X; Dobrolecki LE; Wei W; Lewis MT; Dave B; Chang JC; Landis MD; Creighton CJ; Mancini MA; Tweardy DJ
Oncogene; 2015 Mar; 34(11):1341-53. PubMed ID: 24681959
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo.
Zhang X; Liu P; Zhang B; Mao H; Shen L; Ma Y
Int J Mol Med; 2013 Sep; 32(3):623-8. PubMed ID: 23828376
[TBL] [Abstract][Full Text] [Related]
10. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L
Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of STAT3 decoy oligodeoxynucleotides' synergistic effects on radiation and/or chemotherapy in metastatic breast cancer cell line.
Johari B; Rahmati M; Nasehi L; Mortazavi Y; Faghfoori MH; Rezaeejam H
Cell Biol Int; 2020 Dec; 44(12):2499-2511. PubMed ID: 32841450
[TBL] [Abstract][Full Text] [Related]
12. The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.
Canesin G; Evans-Axelsson S; Hellsten R; Sterner O; Krzyzanowska A; Andersson T; Bjartell A
Eur Urol; 2016 Mar; 69(3):400-4. PubMed ID: 26144873
[TBL] [Abstract][Full Text] [Related]
13. Suppressing the metastatic properties of the breast cancer cells using STAT3 decoy oligodeoxynucleotides: A promising approach for eradication of cancer cells by differentiation therapy.
Rahmati M; Johari B; Kadivar M; Rismani E; Mortazavi Y
J Cell Physiol; 2020 Jun; 235(6):5429-5444. PubMed ID: 31912904
[TBL] [Abstract][Full Text] [Related]
14. Application of decoy oligodeoxynucleotides strategy for inhibition of cell growth and reduction of metastatic properties in nonresistant and erlotinib-resistant SW480 cell line.
Asadi Z; Fathi M; Rismani E; Bigdelou Z; Johari B
Cell Biol Int; 2021 May; 45(5):1001-1014. PubMed ID: 33377576
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
[TBL] [Abstract][Full Text] [Related]
16. Stat3-siRNA induces Fas-mediated apoptosis in vitro and in vivo in breast cancer.
Kunigal S; Lakka SS; Sodadasu PK; Estes N; Rao JS
Int J Oncol; 2009 May; 34(5):1209-20. PubMed ID: 19360334
[TBL] [Abstract][Full Text] [Related]
17. Scoparone exerts anti-tumor activity against DU145 prostate cancer cells via inhibition of STAT3 activity.
Kim JK; Kim JY; Kim HJ; Park KG; Harris RA; Cho WJ; Lee JT; Lee IK
PLoS One; 2013; 8(11):e80391. PubMed ID: 24260381
[TBL] [Abstract][Full Text] [Related]
18. Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity.
Jeon YJ; Jung SN; Yun J; Lee CW; Choi J; Lee YJ; Han DC; Kwon BM
Cancer Sci; 2015 Apr; 106(4):413-20. PubMed ID: 25611086
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
Zhang X; Zhang J; Wang L; Wei H; Tian Z
BMC Cancer; 2007 Aug; 7():149. PubMed ID: 17683579
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment targeting HIF-1α and Stat3 is a potent strategy for prostate cancer therapy.
Reddy KR; Guan Y; Qin G; Zhou Z; Jing N
Prostate; 2011 Dec; 71(16):1796-809. PubMed ID: 21480310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
